Mycobacterium terrae isolated from indoor air of a moisture-damage building sustaine biphasic inflammatory response in mouse lungs

Environmental Health Perspectives

Volumn 110, Issue 11, 2002, Pages 1119-1125

  Jussila, Juha ^a   Komulainen, Hannu ^a   Huttunen, Kati ^a   Roponen, Marjut ^a   Iivanainen, Eila ^a   Torkko, Pirjo ^a   Kosma, Veli Matti ^a   Pelkonen, Jukka ^a   Hirvonen, Marija Riitta ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Brochoalveolar lavage; Cytokines; Inflammation; Intratracheal instillation; Lung; Moisture damaged building; Mycobacterium terrae; Nitric oxide

Indexed keywords

ALBUMIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NITRIC OXIDE SYNTHASE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BUILDING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; IMMUNOSTIMULATION; INDOOR AIR POLLUTION; INOCULATION; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOCYTE MIGRATION; LUNG LAVAGE; LUNG TOXICITY; LYMPHOCYTE; MACROPHAGE; MOISTURE; MONONUCLEAR CELL; MOUSE; MYCOBACTERIUM TERRAE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TERRAE;

EID: 0036851393     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.021101119     Document Type: Article

References (57)

1. Andersson MA, Nikulin M, Köljalg U, Andersson MC, Rainey F, Reijula K, et al. 1987. Bacteria, molds, and toxins in water-damaged building materials. Appl Environ Microbiol 63:387-393.
2. Asano K, Chee CBE, Gaston B, Lilly CM, Gerard C, Drazen JM, et al. 1994. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91:10089-10093.
3. Barnes PJ, Chung KF, PAge CP. 1998. Inflammatory mediators of asthma: an update. Pharmacol Rev 50:515-596.
4. Barnes PJ, Kharitonov SA. 1997. Exhaled nitric oxide in monitoring asthma. Drugs Today 10:715-727.
5. Brunekreef B. 1992. Damp housing and adult respiratory symptoms. Allergy 47:498-502.
6. Cassatella MA. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21-26.
7. Chatterjee D, Khoo KH. 1998. Myobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8:113-120.
8. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med 210:93-101.
9. Cunha FQ, Assreuy J, Moss DW, Rees D, Leal LM, Moncada S, et al. 1994. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1 beta. Immunology 81:211-215.
10. Dearborn DG, Yike I, Sorenson WG, Miller MJ, Etzel RA. 1999. Overview of investigations into pulmonary hemorrhage among infants in Cleveland, Ohio. Environ Health Perspect 107(suppl 3):495-499.
11. Denis M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 132:150-157.
12. Donaldson K. 2000. Nonneoplastic lung responses induced in experimental animals by exposure to poorly soluble nonfibrous particles. Inhal Toxicol 12:121-139.
13. Flappan SM, Portnoy J, Jones P, Barnes C. 1999. Infant pulmonary hemorrhage in a suburban home with water damage and mold (Stachybotrys astra). Environ Health Perspect 107:927-930.
14. Flesch IE, Kaufmann SH, 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 59:3213-3218.
15. Fulton SA, Martin TD, Redline RW, Boom WH. 2000. Pulmonary immune responses during primary Mycobacterium bovis-Calmette-Guerin bacillus infection in C57BI/6 mice. Am J Respir Cell Mol Biol 22:333-343.
16. Goodfellow M, Magee JG. 1998: Taxonomy of mycobacteria. In: Mycobacteria: Vol 1. Basic Aspects (Gangadharam PRJ, Jenkins PA, eds). New York: Chapman & Hall, 1-71.
17. Hagmann M. 2000. A mold's toxic legacy revisited. Science 288:243-244.
18. Hibbs JB Jr, Taintor RR, Vavrin Z. 1987. Macrophage cytotoxicity: role of L-arginine deiminase activity and imino nitrogen oxidation to nitrite. Science 235:473-476.
19. Hobbie JE, Daley RJ, Jasper S. 1997. Use of Nuclepore filters for counting bacteria by fluorescence microscopy. Appl Environ Microbiol 33:1225-1228.
20. Holland SM. 1996. Host defence against nontuberculous mycobacterial infections. Semin Respir Infect 11:217-230.
21. Huttunen K, Jussila J, Hirvonen MR, Iivanainen E, Katila ML. 2001. Comparison of mycobacteria-induced cytotoxicity and inflammatory responses in human and mouse cell lines. Inhal Toxicol 13:977-991.
22. Huttunen K, Ruotsalainen M, Iivanainen E, Torkko P, Katila ML, Hirvonen MR. 2000. Inflammatory responses in RAW264.7 macrophages caused by mycobacteria isolated from moldy houses. Environ Toxicol Pharmacol 8:237-244.
23. Jablonska E, Jablonski J, Holownia A. 1999. Role of neutrophils in release of some cytokines and their soluble receptors. Immunol Lett 70:191-197.
24. Janeway CA, Travers P. 1997. The immune system in health and disease: host defence against infection. In Immuno Biology: The immune System in Health and Disease (Janeway CA, Travers P, eds). 3rd ed. Singapore Press, 91:1-9:52.
25. Jones GS, Amirault HJ, Andersen BR. 1990. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis 162:700-704.
26. Jorens PG, Vermeire PA, Herman AG. 1993. L-Arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and airways. Eur Respir J 6:258-266.
27. Jussila J, Komulainen H, Huttunen K, Roponen M, Hälinen A, Hyvärinen A, et al. 2001. Inflammatory responses in mice after intratracheal instillation of spores of Streptomyces californicus isolated from indoor air of a moldy building. Toxicol Appl Pharmacol 171:61-69.
28. Katila ML, Mäntyjärvi RA. 1982. Acridine orange staining of smears for demonstration of Mycobacterium tuberculosis. Eur J Clin Microbiol 1:351-353.
29. Kolb H, Kolb-Bachofen V. 1992. Nitric oxide: a pathogenic factor in autoimmunity. Immunol Today 13:157-160.
30. Kopf M, Baumann H, Freer M, Freudenberg M, Lamers M, Kishimoto T, et al. 1994. Impaired immune and acute-phase responses in interleukin-6 deficient mice. Nature 368:339-342.
31. Koskinen OM, Husman TM, Meklin TM, Nevalainen AI. 1999. The relationship between moisture or mould observations in houses and the state of health of their occupants. Eur Respir J 14:1363-1367.
32. Krisher KK, Kallay MC, Nolte FS. 1988. Primary pulmonary infection caused by Mycobacterium terrae complex. Diagn Microbial Infect Dis 11:171-175.
33. Kristof AS, Goldberg P, Laubach V, Hussain SNA. 1998. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158:1883-1889.
34. Kuze F, Mitsuoka A, Chiba W, Shimizu Y, Ito M, Teramatsu T, et al. 1983. Chronic pulmonary infection caused by Mycobacterium terrae complex. Am Rev Respir Dis 128:561-565.
35. Li XY, Brown D, Smith S, MacNee W, Donaldson K. 1999. Short-term inflammatory responses following intratracheal instillation of line and ultrafine carbon black in rats. Inhal Toxicol 11:709-731.
36. Li XY, Donaldson K, Brown D, MacNee W. 1995. The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation. Am J Respir Cell Mol Biol 13:185-195.
37. Marshall BG, Chambers MA, Wangoo A, Shaw RJ, Young DB. 1997. Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant. Infect Immun 65:1931-1935.
38. Menezes-de-Lima O Jr, Werneck-Barroso E, Cordeiro RS, Henriques MG. 1997. Effects of inhibitors of inflammatory mediators and cytokines on eosinophil and neutrophil accumulation induced by Mycobacterium bovis bacillus Calmette-Guerin in mouse pleurisy. J Leukoc Biol 62:778-785.
39. Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
40. Morrow PE. 1992. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 113:1-12.
41. Moura AC, Werneck-Barroso E, Rosas EC, Henriques MG, Cordeiro RS. 1999. Opposite cellular accumulation and nitric oxide production in vivo after pleural immunization with M. leprae or M. bovis BCG. Int J Mol Med 3:69-74.
42. Palmero DJ, Teres RI, Eiguchi K. 1989. Pulmonary disease due to Mycobacterium terrae. Tubercle 70:301-303.
43. Peters EJ, Morice R. 1991. Military pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient. Chest 100:1449-1450.
44. Pirhonen I, Nevalainen A, Husman T, Pekkanen J. 1996. Home dampness, moulds and their influence on respiratory infections and symptoms in adults in Finland. Eur Respir J 9:2618-2622.
45. Platt SD, Martin CJ, Hunt SM, Lewis CW. 1989. Damp housing, mould growth, and symptomatic health state. Br Med J 24:1673-1678.
46. Rautiala S, Reponen T, Hyvärinen A, Nevalainen A, Husman T, Vehviläinen A, et al. 1996. Exposure to airbone microbes during the repair of moldy buildings. Am Ind Hyg Assoc J 57:279-284.
47. Seiler P, Aichele P, Raupach B, Odermatt B, Steinhoff U, Kaufmann SHE. 2000. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J Infect Dis 18:671-680.
48. Shimizu T, Furumoto H, Takahashi T, Yasuno H, Nishioka K, Muto M. 1999. Lymphadenitis due to Mycobacterium terrae in an immunocompetent patient. Dermatology 198:97-98.
49. Spence TH, Ferris VM. 1996. Spontaneous resolution of a lung mass due to infection with Mycobacterium terrae. South Med J 89:414-416.
50. Spengler J, Neas L, Nakai S, Dockery D, Speizer F, Ware J, et al. 1994. Respiratory symptoms and housing characteristics. Indoor Air 4:72-82.
51. Strachan DP. 1988. Damp housing childhood asthma: validation of reporting of symptoms. Br Med J 297:1223-1226.
52. Taskinen T, Meklin T, Nousiainen M, Husman T, Nevalainen A, Korppi M. 1997. Moisture and mould problems in schools and respiratory manifestations in schoolchildren: clinical and skin test findings. Acta Peadiatr 86:1181-1187.
53. Torkko P, Suutari M, Suomalainen S, Paulin L, Larsson L, Katila ML. 1998. Separation among species of Mycobacterium, terrae complex by lipid analysis: comparison with biochemical tests and 16S rRNA sequencing. J Clin Microbiol 36:499-505.
54. VanHeyningen TK, Collins HL, Russell DG. 1997. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol 158:330-337.
55. Van Snick J. 1990. Interleukin-6: an overview. Annu Rev Immunol 8:253-278.
56. Waegemaekers M, Wageningen N, Brunekreef B, Boleij JSM. 1989. Respiratory symptoms in damp homes. Allergy 44:192-198.
57. Zar JH. 1996. Multiple comparisons. In: Biostatiscal Analysis (Zar JH, ed). 3rd ed. Upper Saddle River NJ:Prentice-Hall Inc., 211-234.